| 000 | 01615 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513060637.0 | ||
| 264 | 0 | _c19941006 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0022-3468 | ||
| 024 | 7 |
_a10.1016/0022-3468(94)90360-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuita, S | |
| 245 | 0 | 0 |
_aWhat is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma. _h[electronic resource] |
| 260 |
_bJournal of pediatric surgery _cJun 1994 |
||
| 300 |
_a746-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 |
_aGenes, myc _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aZaizen, Y | |
| 700 | 1 | _aKaneko, M | |
| 700 | 1 | _aUchino, J | |
| 700 | 1 | _aTakeda, T | |
| 700 | 1 | _aIwafuchi, M | |
| 700 | 1 | _aUtsumi, J | |
| 700 | 1 | _aTakahashi, H | |
| 700 | 1 | _aYokoyama, J | |
| 700 | 1 | _aNishihira, H | |
| 773 | 0 |
_tJournal of pediatric surgery _gvol. 29 _gno. 6 _gp. 746-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0022-3468(94)90360-3 _zAvailable from publisher's website |
| 999 |
_c8077337 _d8077337 |
||